Diagnostic accuracy of point-of-care urine tenofovir test, and associations between metrics of tenofovir use and treatment outcomes in a community ART programme
BACKGROUND: Urine tenofovir (uTFV) and dried blood spot (DBS) tenofovir diphosphate (TFV-DP) concentrations respectively estimate short- and medium-term adherence to tenofovir disoproxil fumarate (TDF)-based antiretroviral therapy (ART). We evaluated the accuracy of a point-of-care uTFV assay, and associations between uTFV/TFV-DP, and viral load and retention outcomes within a South African community ART programme. METHODS: We measured uTFV and DBS TFV-DP concentrations using liquid chromatography-tandem mass spectrometry (LC-MS/MS). We calculated sensitivity and specificity of the point-of-care uTFV assay at the manufacturer-recommended threshold of ≥1500 ng/ml compared to LC-MS/MS. We assessed associations of the point-of-care uTFV assay, and DBS TFV-DP concentrations with concurrent viraemia, and with retention-in-care by 16weeks post-enrolment. RESULTS: Of 196 adults, median age was 44 years, 64.8% (127) were female, and 97.4% (191) were receiving TDF. One hundred and eighty-five (94.4%) had detectable point-of-care uTFV, which had high sensitivity (99.5%, 95% CI 96.5-100%) and moderate specificity (76.9%, 95% CI 46.0-93.8%) for detecting uTFV ≥1500 ng/ml. Two participants had concurrent viraemia ≥1000 copies/ml; of these 50.0% (1/2) (95% CI 9.4-90.5) had undetectable point-of-care uTFV, and 100% (2/2) (95% CI 19.7-100) had TFV-DP <483 fmol/punch. Among participants without viraemia, 97.4% (184/189) (95% CI 93.6-99.0) had detectable uTFV, and 98.4% (186/189) (95.3-99.6) had TFV-DP ≥483 fmol/punch. Point-of-care uTFV and DBS TFV-DP were not associated with retention-in-care. CONCLUSIONS: The point-of-care uTFV assay demonstrated high sensitivity and moderate specificity to detect uTFV. Over 95% of people without viraemia had detectable point-of-care uTFV or high DBS TFV-DP levels, respectively, but these were not associated with 16-week retention-in-care.
Authors
- Yukteshwar Sookrajh (ORCID: https://orcid.org/0000-0001-9029-5153)
- Nigel Garrett (ORCID: https://orcid.org/0000-0002-4530-234X)
- Lara Lewis (ORCID: https://orcid.org/0000-0001-5373-2086)
- Monica Gandhi (ORCID: https://orcid.org/0000-0002-7025-1994)
- Gail Hayward (ORCID: https://orcid.org/0000-0003-0852-627X)
- Natasha Samsunder (ORCID: https://orcid.org/0000-0003-3582-5718)
- Paul K. Drain (ORCID: https://orcid.org/0000-0002-9569-4097)
- Pravi Moodley (ORCID: https://orcid.org/0000-0002-9946-8783)
- Christopher Butler (ORCID: https://orcid.org/0000-0002-0102-3453)
- Jienchi Dorward (ORCID: https://orcid.org/0000-0001-6072-1430)
- Katya Govender (ORCID: https://orcid.org/0000-0001-5753-0107)
- Johan S. van der Molen (ORCID: https://orcid.org/0009-0009-7290-7107)
- Kwena Tlhaku (ORCID: https://orcid.org/0000-0002-2105-9146)
- L.G.K. Naidu (ORCID: https://orcid.org/0000-0001-8516-4554)
Institutions
- University of Cape Town (ZA)
- University of California, San Francisco (US)
- Centre for the AIDS Programme of Research in South Africa (ZA)
- eThekwini Municipality (ZA)
- University of Oxford (GB)
- Africa Health Research Institute (ZA)
- University of KwaZulu-Natal (ZA)
Publication Details
- Journal
- AIDS
- Published
- 2026-11-17
- DOI
- https://doi.org/10.1097/qad.0000000000004656
- Primary Topic
- HIV/AIDS Research and Interventions
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Bill and Melinda Gates Foundation
- Wellcome Trust
- National Institute for Health and Care Research
- Department of Health and Social Care
- Dowager Countess Eleanor Peel Trust
- National Institutes of Health
- National Institute of Allergy and Infectious Diseases